prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria for prostate adenocarcinoma and give endocrine therapy; (2) Serum testosterone <50 ng / dl (1.7 nmol / L); (3) The physical strength of the study subjects is normal, and the karnofsky score exceeds 60 points, and is expected to survive for more than half a year; (4) Patient compliance is good and follow-up studies are possible; (5) Understand and sign the informed consent form. The above five conditions must be met at the same time.
Exclusion criteria
Exclusion criteria: (1) Patients with serious complications of prostate cancer; (2) Allergic to endocrine therapy drugs; (3) At the same time, it has obvious heart, brain and liver diseases; (4) Patients with primary malignant tumors of organs other than prostate cancer; (5) It is the end stage of the tumor, multiple organ failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSA;therapeutic effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood biochemical indexes;Tumor markers; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Chinese Medicine